Tenon Medical (Tenon Medical) Gross-Profit-to-Asset % : 26.17% (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Tenon Medical Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Tenon Medical's annualized Gross Profit for the quarter that ended in Mar. 2024 was $1.88 Mil. Tenon Medical's average Total Assets over the quarter that ended in Mar. 2024 was $7.18 Mil. Therefore, Tenon Medical's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 26.17%.

Tenon Medical Gross-Profit-to-Asset % Historical Data

The historical data trend for Tenon Medical's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tenon Medical Gross-Profit-to-Asset % Chart

Tenon Medical Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Gross-Profit-to-Asset %

6.65

2.17

-6.30

14.24

Tenon Medical Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Gross-Profit-to-Asset %	Get a 7-Day Free Trial									-2.01	8.88	24.92	32.73	26.17

Competitive Comparison of Tenon Medical's Gross-Profit-to-Asset %

For the Medical Devices subindustry, Tenon Medical's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tenon Medical's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tenon Medical's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Tenon Medical's Gross-Profit-to-Asset % falls into.

Tenon Medical Gross-Profit-to-Asset % Calculation

Tenon Medical's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2023 )	/	( (Total Assets (A: Dec. 2022 )	+	Total Assets (A: Dec. 2023 ))	/ count )
	=	1.241	/	( (11.089	+	6.345)	/ 2 )
	=	1.241	/	8.717
	=	14.24 %

Tenon Medical's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	1.88	/	( (6.345	+	8.02)	/ 2 )
	=	1.88	/	7.1825
	=	26.17 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Tenon Medical Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Tenon Medical's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Tenon Medical (Tenon Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tenon Medical Inc (NAS:TNON) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

N/A

Address

104 Cooper Court, Los Gatos, CA, USA, 95032

Website

https://www.tenonmed.com

Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.

Executives

Van Dick Steven M	officer: Chief Financial Officer	HANSEN MEDICAL, INC., 380 N BERNARDO AVENUE, MOUNTAIN VIEW CA 94043
Richard Ginn	director, officer: Chief Technology Officer	104 COOPER COURT, LOS GATOS CA 95032
Steven M Foster	director, officer: CEO and President	104 COOPER COURT, LOS GATOS CA 95032
Stephen Hochschuler	director	C/O TENON MEDICAL, INC., 104 COOPER COURT, LOS GATOS CA 95032
Frank M Fischer	director	9701 JERONIMO, IRVINE CA 92618
Richard M Ferrari	director	2118 WALSH AVENUE, SUITE 210, SANTA CLARA CA 95050
Ivan Howard	director	104 COOPER COURT, LOS GATOS CA 95032
Robert K Weigle	director	104 COOPER COURT, LOS GATOS CA 95032
Ventures Ag Zuhlke	10 percent owner	ZURCHERSTRASSE 39J, SCHLIEREN V8 8952